Company ProfilePremium

Sonablate

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Sonablate - Healthcare showcase

Year Founded & Workforce

2004

117 Employees

Industry

Healthcare

Services

Tumor Ablation
S

Sonablate Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Sonablate Overview

Company Headquarters: North Carolina, US

Founded: 2004

Workforce: ~117

Company Working: Sonablate designs and manufactures HIFU surgical ablation systems that offer physicians and patients both clinical effectiveness and quality-of-life interventions. It also offers laparoscopic invasive hhigh-intensityfocused ultrasound (HIFU) surgical ablation system, fully integrated multi-transducer technology, and ultrasound-based imaging and assessment technology. The company is a leader in the development and advancement of minimally invasive HIFU technology. It is a global leader in HIFU therapies, with over 15,000 patient procedures completed and regulatory clearance in over 50 countries around the globe.

Strategy

Sonablate is focusing mainly on ultrasound-related technologies that support precise and innovative procedures for the treatment of a range of medical conditions. It is also focusing on launching its products in new markets to generate more revenue and gain a customer base.

Company Snapshot

117

Employees

2004

Founded

North Carolina, US

Headquarters

SWOT Analysis

Strengths

  • Global leader in HIFU therapies
  • High level of customer satisfaction
  • Worldwide presence of the company

Weaknesses

  • Less focus on emerging economies

Opportunities

  • Growing target patient population
  • Investment in mergers & acquisitions

Threats

  • Increasing stringency of regulations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
July 2020Product ApprovalSonablate (US) received regulatory approval from the National Medical Products Administration (NMPA), formerly known as the Chinese FDA, for the Sonablate HIFU device for use in the treatment of prostate cancer and benign prostatic hypertrophy (BPH).

Product Offering

  • Sonablate
    • Tumor Ablation

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.